Check4Cancer

Check4Cancer is a UK-based healthcare provider specializing in early cancer detection and diagnostic services. The company offers a comprehensive suite of screening programs for various cancers, including breast, skin, bowel, prostate, cervical, and lung cancer, utilizing clinical pathways designed by specialist consultants. In addition to physical screenings, Check4Cancer provides genetic testing services to assess hereditary risks for cancer through its MyCheck4Cancer brand. Their services are marketed to both individual private clients and corporate partners as part of employee wellness and occupational health programs. Following its acquisition by PAM Group in 2022, the company continues to operate as a leading provider of diagnostic solutions in the UK market.